共 50 条
[11]
Landau D., Israel E., Rivkis I., Et al., The effect of growth hormone on the development of diabetic kidney disease in rats, Nephrol. Dial. Transplant., 18, pp. 694-702, (2003)
[12]
Sugimoto H., Shikata K., Makino H., Et al., Increased gene expression of insulin-like growth factor-I receptor in experimental diabetic rat glomeruli, Nephron, 72, pp. 648-653, (1996)
[13]
Doublier S., Seurin D., Fouqueray B., Et al., Glomerulosclerosis in mice transgenic for human insulin-like growth factor-binding protein-1, Kidney Int., 57, pp. 2299-2307, (2000)
[14]
Bellush L.L., Doublier S., Holland A.N., Et al., Protection against diabetes-induced nephropathy in growth hormone receptor/ binding protein gene-disrupted mice, Endocrinology, 141, pp. 163-168, (2000)
[15]
Flyvbjerg A., Bennett W.F., Rasch R., Et al., Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy and urinary albumin excretion in experimental diabetes in mice, Diabetes, 48, pp. 377-382, (1999)
[16]
Bak M., Thomsen K., Flyvbjerg A., Effects of the somatostatin analogue octreotide on renal function in conscious diabetic rats, Nephrol. Dial. Transplant., 16, pp. 2002-2007, (2001)
[17]
Raz I., Rubinger D., Popovtzer M., Et al., Octreotide prevents the early increase in renal insulin-like growth factor biding protein 1 in streptozotocin diabetic rats, Diabetes, 47, pp. 924-930, (1998)
[18]
Doi T., Striker L.J., Gibson C.C., Et al., Glomerular lesions in mice transgenic for growth hormone and insulin-like growth factor-I, Am. J. Pathol., 137, pp. 541-552, (1990)
[19]
Tsuchida K.I., Cronin B., Sharma K., Novel aspects of transforming growth factor-beta in diabetic kidney disease, Nephron, 92, pp. 7-21, (2002)
[20]
Yamagishi S.I., Inagaki Y., Okamoto T., Et al., Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells, Kidney Int., 63, pp. 464-473, (2003)